Skip to main content
. 2017 Dec 5;9(1):881–891. doi: 10.18632/oncotarget.22971

Table 3. Different inheritance model analyses of rs11646213 in CDH13 between NSCLC and control groups (After adjusted for gender and age).

Models Genotypes Control (n, %) NSCLC (n, %) OR (95% CI) P-value* AIC BIC
Codominant A/A 316 (71.2%) 292 (64.3%) 1.00 0.011 1207.6 1490.8
A/T 118 (26.6%) 138 (30.4%) 1.16 (0.84–1.61)
T/T 10 (2.2%) 24 (5.3%) 3.43 (1.47–8.00)
Dominant A/A 316 (71.2%) 292 (64.3%) 1.00 0.110 1212.0 1490.4
A/T-T/T 128 (28.8%) 162 (35.7%) 1.30 (0.95–1.77)
Recessive A/A-A/T 434 (97.8%) 430 (94.7%) 1.00 0.004 1206.4 1484.8
T/T 10 (2.2%) 24 (5.3%) 3.26 (1.41–7.56)
Overdominant A/A-T/T 326 (73.4%) 316 (69.6%) 1.00 0.640 1214.4 1492.8
A/T 118 (26.6%) 138 (30.4%) 1.08 (0.78–1.49)
Log-additive --- --- --- 1.38 (1.05–1.81) 0.019 1209.1 1487.5

*Statistical significant threshold was set at P < 0.007 (0.05/7) determined by Bonferroni correction.